EUVIMEDEUVIMED entdecken
Crossref

Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers

Radhika Gutta, Emily Teslow, Ellen Jaeger, Melissa C Stoppler, Calvin Chao, Fawzi Abu Rous, Bindu Potguari, Shirish Gadgeel

Clinical Lung Cancer · 2025-06 · 26 (4) · 307-313.e7

DOI: 10.1016/j.cllc.2025.02.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2025-06. Verfasst von Radhika Gutta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Henry Ford Cancer Center, Detroit, MI. Electronic address: rgutta1@hfhs.org. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Black or African American, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Tempus AI Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: EGFR alterations have significant therapeutic implications in lung cancer (LCa), yet their prevalence and co-mutational patterns in African American populations remain understudied. This study analyzes EGFR-mutant LCa across races using the Tempus database. METHODS: De-identified records sequenced via Tempus xT assay, (595 to 648 gene DNA panel) were included if they had ≥ 1 pathogenic EGFR mutation (short variants (SVs), copy number amplifications (CNAs), or fusions). Race was determined based on recorded clinical records. Co-mutations were restricted to genes with ≥ 5% frequency in at least 1 race. Statistical analyses were performed using chi-squared tests with Bonferroni or false discovery rate adjustments for multiple testing. RESULTS: Among 17,482 LCa samples, EGFR alterations occurred in 8.9% of CA, 7.6% of BAA, 39% of API, 15% of other races, and 12% of unknown races. Exon 19 deletions (P = .017) and L858R mutations (P < .001) varied by race, with higher L858R frequency in CA compared to BAA (P = .034) and in API compared to CA (P = .006). EGFR copy number variants (CNVs) were highest in BAA (P < .001). TP53 alterations occurred at a higher frequency in patients with a history of smoking, those with high tumor mutational burden (TMB), and high PD-L1. KMT2C co-mutations were significantly more common in BAA (13%) compared to CA (3%) and API (4%) (q = 0.003). Similarly, GLI1 co-mutations were most frequent in BAA (5.8%) compared to 1.5% in CA and 0% in API patients (q = 0.025). CONCLUSIONS: EGFR mutation subtypes and co-mutations differ by race. KMT2C may influence TMB and immunotherapy response, while GLI1 is linked to TKI resistance. TP53 alterations were more commen in smokers, and patients with high PDL-1 and TMB, highlighting additional factors that drive tumors with these alterations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBlack or African AmericanLung NeoplasmsMutationRacial GroupsAgedFemaleHumansMaleMiddle AgedDNA Copy Number VariationsDNA Mutational AnalysisErbB Receptors

Stichwörter der Autor:innen

Nonsmall cell lung cancerRacial diversityTargeted therapy

Substanzen

Biomarkers, TumorEGFR protein, humanErbB Receptors

Autor:innen und Institutionen

  • Henry Ford Cancer Center, Detroit, MI. Electronic address: rgutta1@hfhs.org.
  • Tempus AI, Inc, Chicago, IL.
  • Henry Ford Cancer Center, Detroit, MI.

Förderung

  • Tempus AI Inc

Zitieren

APA

Gutta, R., Teslow, E., Jaeger, E., Stoppler, M. C., Chao, C., Rous, F. A., Potguari, B., & Gadgeel, S. (2025). Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers. Clinical Lung Cancer, 26(4), 307-313.e7. https://doi.org/10.1016/j.cllc.2025.02.008

Vancouver

Gutta R, Teslow E, Jaeger E, Stoppler MC, Chao C, Rous FA, et al. Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers. Clinical Lung Cancer. 2025;26(4):307-313.e7. doi:10.1016/j.cllc.2025.02.008

BibTeX
@article{Gutta2025,
  author = {Gutta, Radhika and Teslow, Emily and Jaeger, Ellen and Stoppler, Melissa C and Chao, Calvin and Rous, Fawzi Abu and Potguari, Bindu and Gadgeel, Shirish},
  title = {Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers},
  journal = {Clinical Lung Cancer},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {307--313.e7},
  doi = {10.1016/j.cllc.2025.02.008}
}
Kostenlos starten →